Cargando…
Effect of erlotinib combined with cisplatin on IL-6 and IL-12 in mice with Lewis lung cancer
Effect of erlotinib combined with cisplatin on tumor growth, interleukin-6 (IL-6) and interleukin-12 (IL-12) in mice with Lewis lung cancer (LLC) was investigated. Forty-four pure inbred SPF C57BL/6J mice were modeled for LLC and randomized into groups A, B, C and D (n=11 each group). Mice in group...
Autores principales: | Zhang, Xu, Chen, Jinliang, Jin, Hongsong, Zhao, Wei, Chang, Zhibo, Wu, Huijing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285801/ https://www.ncbi.nlm.nih.gov/pubmed/32566018 http://dx.doi.org/10.3892/ol.2020.11632 |
Ejemplares similares
-
Combination Erlotinib-Cisplatin and Atg3-Mediated Autophagy in Erlotinib Resistant Lung Cancer
por: Lee, Jasmine G., et al.
Publicado: (2012) -
IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib
por: Fernando, Romaine I., et al.
Publicado: (2016) -
Chronopharmacology and Mechanism of Antitumor Effect of Erlotinib in Lewis Tumor-Bearing Mice
por: Wang, Peipei, et al.
Publicado: (2014) -
Genetic Variations of IL-12B, IL-12Rβ1, IL-12Rβ2 in Behcet's Disease and VKH Syndrome
por: Li, Xinyu, et al.
Publicado: (2014) -
Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2
por: Horton, Brendan L., et al.
Publicado: (2023)